Entries in Johnson & Johnson (8)
A former saleswoman for medical device maker Acclarent was awarded $3.5 million as her share of an $18 million settlement of a whistleblower suit alleging false marketing claims.
You might expect corrupt companies to downplay and devalue the principles of market competition. In fact the opposite is true.
A plaintiffs law firm that specializes in securities class action litigation was ordered to pay sanctions to Boeing over a lawsuit the firm pressed even though the crucial witness behind it didn't know anything relevant.
Reporting companies filed Form SDs with the SEC Monday, and most said its not fully clear if their products contain conflict minerals from Africa's Congo region.
The FCPA Blog wanted to explore the idea of the dual-hatted compliance officer -- the one who occupies both the general counsel and chief compliance officer roles in a company. We talked with the former SEC Chairman and now Kalorama Partners CEO, Harvey Pitt. The conversation turned into a thoughtful exchange about what it means to be an independent and effective CCO in any industry today. Executive editor Julie DiMauro asked the questions for the FCPA Blog.
Health care giant Johnson & Johnson will pay more than $2.2 billion to resolve criminal and civil claims arising from allegations of kickbacks to U.S. doctors and improper marketing claims about three of its prescription drugs.